IMCC - IM Cannabis Corp.
1.3101
-0.060 -4.572%
Share volume: 6,445
Last Updated: 04-07-2025
Pharmaceutical Products/Medicinal Chemicals:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.37
-0.06
-0.04%
Fundamental analysis
15%
Profitability
0%
Dept financing
25%
Liquidity
0%
Performance
30%
Performance
5 Days
-13.81%
1 Month
-28.02%
3 Months
-37.32%
6 Months
-37.32%
1 Year
-37.32%
2 Year
-37.32%
Key data
Stock price
$1.31
DAY RANGE
$1.30 - $1.49
52 WEEK RANGE
$1.30 - $2.17
52 WEEK CHANGE
-$37.32
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
Company detail
CEO: Oren Shuster
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing
IM Cannabis Corp. engages in breeding, growing, and supply medical cannabis products. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers.
Recent news
